3.74 USD
↘ 0.07 (1.84%)AT CLOSE (03:59 PM EDT)
Unicycive Therapeutics, Inc. Common Stock
UNCYNASDAQ • USD
3.35
↘ 0.39 (10.53%)
POST MARKET (AS OF 07:33 PM EDT)
Post Market
AS OF 07:33 PM EDT
3.35
↘ 0.39 (10.53%)
Market: OPEN
UNCY is currently priced at $3.35. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, UNCY appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 30, 2026.
Open?$3.77
High?$3.93
Low?$3.62
Prev. Close?$3.81
Volume?1.2M
Avg. Volume?1.0M
VWAP?$3.71
Rel. Volume?1.19x
Bid / Ask
Bid?$3.24 × 100
Ask?$4.29 × 100
Spread?$1.05
Midpoint?$3.77
Valuation & Ratios
Market Cap?106.1M
Shares Out?27.9M
Float?27.4M
Float %?98.2%
P/E Ratio?N/A
P/B Ratio?1.99
EPS?-$1.26
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
Employees
22
Market Cap
106.1M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-07-13
Address
1975 W. EL CAMINO REAL, SUITE 204
MOUNTAIN VIEW, CA 94040
Phone: 650-384-0642
MOUNTAIN VIEW, CA 94040
Phone: 650-384-0642
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?3
Momentum?65
Short Sent.?51
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.01Distress
Confidence?50%Low
Short InterestHigh
Short % of Float?17.84%High
Short Interest?4.9M
Days to Cover?4.8
Free Float27.4M
Avg Daily Volume1.0M
Settlement Date2026-10-15
Financial Health
Current Ratio?3.81Strong
Quick Ratio?3.81Strong
Cash Ratio?2.36Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?1.99CHEAP▾
Peers100
S&P74
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.9CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-66.1%WEAK▾
S&P3
ROA?-48.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-27848000
Enterprise Value?$61.9M
Fundamentals ratios updated end of day